IV stem cell infusion vs local injection: what's the difference?

After concentrated stem cells are extracted from bone marrow, the next step is returning them to the patient's body, which can be done in several ways depending on the treatment goal. The two most common methods in regenerative medicine are intravenous (IV) infusion and local (targeted) injection. Each serves a different purpose and suits different indications.

IV infusion releases cells directly into the bloodstream, allowing them to circulate throughout the body and potentially reach multiple organs needing repair. This method is typically used when the goal is a whole-body regenerative effect, such as strengthening the immune system or renewing blood vessels body-wide. Its advantage is reaching multiple systems at once; its limitation is that the concentration reaching any single site may be lower than a direct local injection.

Local injection delivers cells directly to a target site — a joint, muscle, scalp, facial skin or genital tissue. It suits cases where a clearly localised problem needs a high cell concentration, such as joint degeneration, patchy hair loss, or vascular decline in genital tissue. Its advantage is delivering a concentrated dose exactly where needed, though it does not reach other body systems the way IV infusion does.

Cheongdam Cell Clinic uses IV infusion for its flagship 淸(Rejuvenation)CELL programme, which targets whole-body renewal — the clinic states its aim there is strengthening immunity and regenerating blood vessels broadly. Its other, goal-specific programmes use local injection at the target site: 性(Sex)CELL is injected directly into genital tissue, 美(Beauty)CELL and 毛(Hair)CELL into facial skin and scalp, and 活(Vitality)CELL into the painful joint or muscle.

Choosing the right delivery method is primarily a medical decision, not a matter of patient preference. The treating physician assesses which method better suits the patient's symptoms and goals. In some cases both methods may be combined in the same visit — IV infusion for a whole-body effect alongside local injection for a specific problem — depending on the physician's case-by-case assessment.

In terms of safety, both methods are considered low-risk when performed by an experienced physician at a properly equipped facility. IV infusion requires extra monitoring during and after the cell delivery since the cells enter the bloodstream directly, while local injection carries site-specific risks such as swelling, bruising or infection at the injection point — side effects the clinic's own materials explicitly note as possible.

Patients considering any Cheongdam Cell Clinic programme should ask clearly which delivery method it uses, how long it takes, and how to prepare before and after the procedure, so they can plan travel and recovery time appropriately — especially international patients working with a limited schedule.